Laura E. Niklason - 15 Sep 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director, 10%+ Owner
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
15 Sep 2022
Net transactions value
+$8,280
Form type
4
Filing time
19 Sep 2022, 16:48:07 UTC
Previous filing
13 Jun 2022
Next filing
12 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $8,280 +2,000 +0.17% $4.14 1,160,240 15 Sep 2022 Direct
holding HUMA Common Stock 510,161 15 Sep 2022 By spouse
holding HUMA Common Stock 18,930,004 15 Sep 2022 By Ayabudge LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.